21/05/2026 21:18
|
Medical, Health & Aged Care
Randomized controlled trial will evaluate both symptom progression and underlying biology
SAN MATEO, Calif.--BUSINESS WIRE--
Baszucki Group today announced a £1.17 million grant to support a...